Faycal Moujane
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Faycal Moujane has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Huinan Liu
Department of Bioengineering, University of California, Riverside, 900 University Avenue, Riverside, California 92521, United States
1 shared publication - John Y. Lee
Cornea Division, Stein Eye Institute, University of California Los Angeles, Los Angeles, CA 90095, USA
1 shared publication - Jun Liu
Department of Materials Science and Engineering, University of California Los Angeles, Los Angeles, CA 90095, USA
1 shared publication - Siddharth Srivastava
Department of Materials Science and Engineering, University of California Los Angeles
1 shared publication - Sophie X. Deng
Cornea Division, Stein Eye Institute, University of California Los Angeles
1 shared publication - Tieyi Li
Department of Materials Science and Engineering, University of California Los Angeles, Los Angeles, CA 90095, USA
1 shared publication
Latest Publications
- Open Access
- 23 February 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (3) , 141
On the Feasibility of SERS-Based Monitoring of Drug Loading Efficiency in Exosomes for Targeted Delivery
Cancer, a significant cause of mortality, necessitates improved drug delivery strategies. Exosomes, as natural drug carriers, offer a more efficient, targeted, and less toxic drug delivery system compared to direct dispersal methods via ingestion or injection. To be successfully implemented as drug carriers, efficient loading of drugs into exosomes is crucial, and a deeper understanding of the loading mechanism remains to be solved. This study introduces surface-enhanced Raman scattering (SERS) to monitor drug loading efficacy at the single vesicle level. By enhancing the Raman signal, SERS overcomes limitations in Raman spectroscopy. A gold nanopyramids array-based SERS substrate assesses exosome heterogeneity in drug-loading capabilities with the help of single-layer graphene for precise quantification. This research advances targeted drug delivery by presenting a more efficient method of evaluating drug-loading efficiency into individual exosomes through SERS-based monitoring. Furthermore, the study explores leveraging osmotic pressure variations, enhancing the efficiency of drug loading into exosomes.
- 23 February 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (3) , 141
Open AccessOn the Feasibility of SERS-Based Monitoring of Drug Loading Efficiency in Exosomes for Targeted Delivery
Cancer, a significant cause of mortality, necessitates improved drug delivery strategies. Exosomes, as natural drug carriers, offer a more efficient, targeted, and less toxic drug delivery system compared to direct dispersal methods via ingestion or injection. To be successfully implemented as drug carriers, efficient loading of drugs into exosomes is crucial, and a deeper understanding of the loading mechanism remains to be solved. This study introduces surface-enhanced Raman scattering (SERS) to monitor drug loading efficacy at the single vesicle level. By enhancing the Raman signal, SERS overcomes limitations in Raman spectroscopy. A gold nanopyramids array-based SERS substrate assesses exosome heterogeneity in drug-loading capabilities with the help of single-layer graphene for precise quantification. This research advances targeted drug delivery by presenting a more efficient method of evaluating drug-loading efficiency into individual exosomes through SERS-based monitoring. Furthermore, the study explores leveraging osmotic pressure variations, enhancing the efficiency of drug loading into exosomes.